Showing results (2961-2970 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 8, 2003
Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategiesS Taddei, L Ghiadoni, A Virdis, et al.Current Pharmaceutical Design|May 9, 2013
Supercritical fluid particle design for poorly water-soluble drugs (review)Yongda SunCurrent Pharmaceutical Design|May 9, 2013
Factors affecting residual platelet aggregation in prasugrel treated patientsDimitrios Alexopoulos, Ioanna Xanthopoulou, Angelos Perperis, et al.Current Pharmaceutical Design|May 10, 2013
Small cationic antimicrobial peptidomimetics: emerging candidate for the development of potential anti-infective agentsSandeep Lohan, Gopal Singh BishtCurrent Pharmaceutical Design|May 10, 2013
Calix[n]arenes as goldmines for the development of chemical entities of pharmaceutical interestEduardo Vinícius Vieira Varejão, Angelo de Fátima, Sergio Antonio FernandesCurrent Pharmaceutical Design|April 12, 2013
Agonist replacement for stimulant dependence: a review of clinical researchWilliam W Stoops, Craig R RushCurrent Pharmaceutical Design|April 12, 2013
Addictions and stress: clues for cocaine pharmacotherapiesR Picetti, S D Schlussman, Y Zhou, et al.Current Pharmaceutical Design|April 12, 2013
Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid systemOlga Valverde, Marta Rodríguez-ÁriasCurrent Pharmaceutical Design|April 18, 2013
Brief daily episode of normoxia inhibits cardioprotection conferred by chronic continuous hypoxia. Role of oxidative stress and BKCa channelsJan Neckár, Gudrun H Borchert, Patricie Hlousková, et al.Current Pharmaceutical Design|April 18, 2013
Supplementation of creatine and ribose prevents apoptosis and right ventricle hypertrophy in hypoxic heartsAnna Caretti, Paola Bianciardi, Marina Marini, et al.Pageof 1,008